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Abstract
Background: Ophiopogon japonicas (L.f) Ker-Gawl has been used as a traditional Chinese medicine to cure acute
and chronic inflammation and cardiovascular diseases including thrombotic diseases for thousands of years. Previous
phytochemical studies showed that O. japonicus contained compounds with anti-inflammatory activity. The aim of this
study was to identify and isolate compounds with anti-inflammatory activity from the rhizome of O. japonicas.
Methods: Compounds were isolated by various column chromatography and their structures were identified in terms
of nuclear magnetic resonance spectrum (NMR) and mass spectrum (MS). To measure the anti-inflammatory effects of
thirteen compounds in LPS-induced RAW 264.7 macrophage cells, we used the following methods: cell viability assay,
nitric oxide assay, enzyme-linked immunosorbent assay, quantitative real-time PCR analysis and western blotting analysis.
Results: One new and twelve known compounds (mainly homoisoflavonoids) were extracted from O. japonicas,
in which 4′-O-Demethylophiopogonanone E (10) was considered as a new compound, additionally, compounds
4-O-(2-Hydroxy-1- hydroxymethylethyl)-dihydroconiferyl alcohol (2) and 5,7-dihydroxy-6-methyl-3-(2′, 4′-dihydroxybenzyl)
chroman-4-one (12) were isolated from the rhizome of O. japonicas for the first time. The isolated compounds Oleic acid (3),
Palmitic acid (4), desmethylisoophiopogonone B [5,7-dihydroxy-3-(4′-hydroxybenzyl)-8- methyl- chromone] (5), 5,7-dihydroxy-
6-methyl-3-(4′-hydroxybenzyl) chromone (7) and 10 significantly suppressed the production of NO in LPS-induced RAW 264.
7 cells. Especially compound 10 showed the strongest effect against the production of the pro-inflammatory cytokine IL-1β
and IL-6 with the IC50 value of 32.5 ± 3.5 μg/mL and 13.4 ± 2.3 μg/mL, respectively. Further analysis elucidated
that the anti-inflammatory activity of compound 10 might be exerted through inhibiting the phosphorylation of
ERK1/2 and JNK in MAPK signaling pathways to decrease NO and pro-inflammatory cytokines production.
Conclusions: Our results indicated that 4′-O-Demethylophiopogonanone E can be considered as a potential
source of therapeutic medicine for inflammatory diseases.
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Background
Inflammation is a biological response of tissue in attempt-
ing self-protection against harmful stimuli, caused by a
mechanical or biological agent or by an aberrant auto-
immune response [1]. Macrophages play a vital role in
inflammatory response in the initiation, maintenance and
resolution of inflammation [2]. In macrophages,
lipopolysaccharide (LPS), a well-known endotoxin, in-
duces the release of numerous pro-inflammatory media-
tors such as inducible nitric oxide synthase (iNOS) and
inflammatory cytokines, including interleukin-1β (IL-
1β) and interleukin-6 (IL-6), which play a major role in
the pathogenesis of various inflammatory disorders and
serve as significant biomarkers for the assessment of
the inflammatory process [3–6]. iNOS is a protein
whose expression is regulated by activation of NF-κB,
which contribute to the production of NO [7, 8]. Fur-
thermore, mitogen-activated protein kinases (MAPKs),
including extracellular signal-regulated kinases (ERK1/
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2), c-Jun NH2-terminal kinases (JNK) and p38, play
important roles in regulation of the inflammatory
response by mediators. The signaling pathways of
MAPKs can lead to the activation of NF-κB and induce
expression of pro-inflammatory genes, including IL-1β,
IL-6 and iNOS [9–11].
The plant Ophiopogon japonicus (L.f ) Ker-Gawl is
widely distributed in Southeast Asia, especially in most
areas of China. Its rhizome is the primary medical por-
tion and has been used as a traditional Chinese medicine
to treat the inflammatory diseases for thousands of years
[12]. O. japonicus is an important nourishing-yin drug in
the traditional Chinese herbs with various bioactivities,
including anti-inflammation, anti-cardiovascular dis-
eases, anti-tumor, anti-aging, immunoregulation [13].
Previous phytochemical studies showed that the rhizome
of O. japonicas contained homoisoflavonoids, saponins,
amides, monoterpene glycosides, and so on [14].
The study of the biological functions of O. japonicas
has been limited largely to demonstration of antioxi-
dant activities in vitro. Few studies have been per-
formed to explore the relationship between the
bioactive constituents of O. japonicas and their anti-
inflammatory properties. Moreover, the molecular
mechanisms underlying anti-inflammatory activities of
O. japonicus remain unclear in the literature. In this re-
port, we describe the isolation and identification of the
compounds extracted from O. japonicus, followed by
an evaluation of the anti-inflammatory activities of
these compounds. This work was aimed to identify the
chemical components with anti-inflammatory activity
from O. japonicus and to demonstrate their targeted




The radix of O. japonicus were purchased from Kangmei
Pharmaceutical Co. Ltd., Guangdong, China and were
authenticated by Ph. D. Zhi-Hai Huang, department of
the Second Institute of Clinical Medicine, Guangzhou
University of Chinese medicine, Guangzhou, China. The
voucher specimens are deposited at the Guangdong Provin-
cial Academy of Chinese Medical Sciences for future refer-
ence, and the voucher specimen number is 110811881.
Instruments
1D-and 2D-NMR spectra data were obtained on a
Bruker Avance 300 and 500 NMR spectrometer, with
TMS as an internal standard. Electrospray ionization
mass spectra (ESI-MS) were measured on a Thermo
Scientific Finnigan LTQ mass spectrometer, and Prepara-
tive HPLC was conducted using a Waters 2545 Binary
gradient module instrument with 2998 Photodiode Array
Detector. Column chromatography (CC) separations
were performed with D101 resin column (Beijing
greenherbs Co. Ltd., China), silica gel (100–200 mesh,
Qingdao Haiyang Chemical Co. Ltd., China), Sephadex
LH-20 (Pharmcia Biotech AB, Uppsala, Sweden). TLC
was carried out on glass precoated silica gel GF254
plates (Yantai Chemical Industrial Institute, China) and
spots were visualized under UV light ((k = 254 nm or
366 nm) or by spraying with 10% (v/v) sulfuric acid in
ethanol followed by heating to 105 °C. Real-time PCR
(Rrism 7500, Applied Biosystems), Nano Drop 2000C
Spectrophotometer (Thermo Scientific) and Chemidoc
imaging system (BIO-RAD) were for the cell assay.
Extraction and isolation
The extraction and isolation of the compounds was
shown in Fig. 1. The rhizome of O. japonicus (15.0 Kg)
was exhaustively extracted through refluxing three times
with 70% ethanol (15 × 3 L) for 2 h. Then the aqueous
alcohol solution was evaporated under reduced pressure
at 55 °C. The concentrated liquor was mixed with four
times the volume of 95% ethanol solution, overnight at
4 °C, then filtered and concentrated under vacuum to
yield a viscous residue. The residue was suspended in
water, and then was subjected to a D101 resin column
chromatography and eluted successively with water, 30%,
50%, 70% and 90% ethanol. The 70% ethanol elution was
collected and concentrated under vacuum to yield the
extraction (marked as ROJ-ext, 13.0 g). The ROJ-ext was
subjected to silica gel column eluted with CHCl3-
CH3OH (100:0→ 85:15) to obtain six subfractions
(Frc.1-6). Frc.1 and Frc.2 was applied to Sephadex LH-
20 with CHCl3-CH3OH (1:1) as an eluant to provide
Frc.1 A2A, and then were further purified by silica gel
column eluted with CHCl3-CH3OH (100:1) to afford
compound 1 (15.7 mg). Frc.2 B was applied to
PHPLC with C2H3N-CH2O2 (35:65) as an eluant to
provide (compound 2, 10.4 mg). Frc.3 was applied to
Sephadex LH-20 with CHCl3-CH3OH (1:1) as an elu-
ant to provide Frc.3 A (compound 3, 19.4 mg) and
Frc.3 B, the Frc.3 B was purified by silica gel column
eluted with CHCl3-CH3OH (100:1→ 100:2) to afford
compound 4 (6.2 mg). Frc.4 was applied to PHPLC
with C2H3N-CH2O2 (35:65) as an eluant to provide
compound 5 (10.7 mg), compound 6 (9.9 mg), com-
pound 7 (10.2 mg) and compound 8 (10.9 mg). Frc.5
was applied to Sephadex LH-20 with CHCl3-CH3OH
(1:1) as an eluant to provide compound 9 (9.7 mg),
compound 10 (9.5 mg), compound 11 (6.2 mg) and
compound 12 (8.1 mg). Frc.6 was applied to silica
gel column eluted with CHCl3-CH3OH (100:5→
100:7→ 100:9) and re-crystallisation to provide com-
pound 13 (7.3 mg).
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Cell culture
The mouse RAW264.7 macrophage cell line was pur-
chased from the cell bank of the Chinese Academy of
Sciences (CAS, Shanghai, China). Cells were maintained
at 37 °C in a humidified atmosphere containing 5% CO2
in Dulbecco′s Modified Eagle Medium (DMEM, Sigma,
St. Louis, Mo, USA) supplemented with 10% heat-
inactivated fetal bovine serum (FBS, Sigma).
Cell viability assay
The cytotoxicity of the isolated compounds toward
RAW264.7 macrophage cells were evaluated by a con-
ventional MTT assay as reported previously [15]. RAW
264.7 cells (1.0 × 105cells/well) were given a volume of
100 μl to 96-well plates and incubated for 24 h and then
treated with or without different concentrations of com-
pounds (1, 5, 25, 50 and 100 μg/mL). Dimethyl
sulphoxide (DMSO) was used to dissolve the dried sam-
ples, and its final concentration of DMSO in the culture
medium was maintained at less than 0.1% (v/v). The cul-
ture plates were kept at 37 °C with 5%CO2 and the assay
for each concentration of extracts were performed in
triplicates. After additional 24 h incubation, the medium
was discarded, and then new medium without PBS was
added, and the cells were incubated for 4 h with a solu-
tion of 5 mg/mL MTT. The supernatant was removed
carefully, and 200 μL DMSO was added to dissolve the
formazan crystals. The plate was shaken for 10 mins,
and the absorbance was recorded on a Thermo Scientific
microplate spectrophotometer (Thermo Fisher Scientific
Inc., Waltham, MA, USA) at the wavelength of 490 nm.
Nitric oxide assay
The accumulation of nitrite, an indicator of NO produc-
tion in the culture medium, was measured with the
Griess reagent [16]. RAW264.7 cells were plated at 4 ×
105 cells/mL in 24 wells- culture plates. After 24 h incu-
bation, cells were pre-incubated in medium with or
without various concentrations of compounds for 2 h.
The experimental groups were then stimulated with LPS
(final concentration 1 μg/mL) at 37 °C for another 24 h,
in while the dexamethasone (DXM) group at the con-
centration of 50 μg/mL was as a positive control. Subse-
quently, the supernatant was collected. Fifty microlitres
of cell culture medium were mixed with 50 μL of Griess
reagent (equal volumes of 1% sulphanilamide in 5%
phosphoric acid and 0.1% N-1-naphtylethylenediamine
dihydrochloride in distilled water), incubated at room
Fig. 1 Isolation processes of compounds 1–13
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temperature for 10 min, and then the absorbance at
540 nm was measured in a microplate reader. Nitrite
concentrations in the supernatant were determined by
comparison with a sodium nitrite standard curve.
Enzyme-linked immunosorbent assay
The supernatant above-mentioned in the 24 wells-
culture plates were collected. Pro-inflammatory cyto-
kines (IL-1β and IL-6) levels in culture medium were
determined using commercially available enzyme-linked
immunosorbent assay (ELISA) kits (R&D Systems) ac-
cording to the manufacturer’s instructions.
Quantitative real-time pcr analysis
The cells were seeded in 6-well plates (1.0 × 106 cells/
well) and the groups were the same as above. The total
RNA was extracted with Tripure reagent. The total RNA
was stored at −80 °C until use. Then Transcriptor First
Stand cDNA Synthesis Kit (Roche, USA) was used to re-
verse transcribe complementary DNA. Subsequently,
quantitative real-time PCR was performed by ABI
Prism7500 Sequence Detection System using SYBR
Green Master Rox (Roche, USA) at the standard condi-
tions. The nucleotide sequences of the primers used
were as follows: IL-1β (forward, 5′-TGA AGG GCT
GCT TCC AAA CCT TTG ACC-3′, reverse, 5′-TGT
CCA TTG AGG TGG AGA GCT TTC AGC-3′), IL-6
(forward, 5′-TAC TCG GCA AAC CTA GTG CG-3′,
reverse, 5′-GTG TCC CAA CAT TCA TAT TGT CAG
T-3′), iNOS (forward, 5′- CGG CAA ACA TGA CTT
CAG GC -3′, reverse, 5′- GCA CAT CAA AGC GGC
CAT AG -3′), GAPDH (forward, 5′-TTT GTC AAG
CTC ATT TCC TGG TAT G-3′, reverse, 5′-TGG GAT
AGG GCC TCT CTT GC-3′). The results were expressed
as the ratio of optical density to GAPDH. Relative expres-
sion levels were calculated using the 2−△△Ct method [17].
All qRT-PCR assays were repeated at three times.
Western blotting analysis
Western blotting was performed according to a standard
method [18]. The cells were seeded in 6-well plates
(1.0 × 106 cells/well) and the groups were the same as
above. Proteins were extracted from cells in the ice-cold
RIPA lysis buffer (50 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1%
SDS) containing with PMSF, and incubated with 40 min
on the ice. After centrifugation at 12,000 rpm for
20 min, the supernatant was collected. The protein
concentration was determined using the BCA kit
(Sigma-Aldrich) according to the manufacturer’s in-
struction. The protein from each sample was boiled
with loading buffer for 10 min, forty microgram of pro-
tein per lane was electrophoresed through 12% SDS-
PAGE gel, and followed by transferring to a PVDF
membranes, which were activated in methanol. The
membrane was blocked with 5% skim milk for 1 h at
room temperature, and then incubated with primary
antibodies (Cell Signaling Technology Inc., Beverly,
MA, USA) at 1:1000 (v/v) dilution in 5% BSA at 4 °C
overnight, and washed three times with TBST buffer.
The membrane was followed by incubation for 1 h at
room temperature with horseradish peroxidase-
conjugated anti-rabbit IgG secondary antibody (CST).
Then the blots were washed with TBST buffer three
times and visualized by an enhanced chemiluminescent
(ECL) detection solution.
Statistical analysis
Statistical comparisons were performed between the
control and treated groups. The data obtained from
three independent experiments were reported as mean
values ± standard deviations. Statistical analysis was car-
ried out using SPSS 19.0 software. The data were sub-
jected to analysis of variance (ANOVA) for comparing
three or more groups, a significant difference was as-
sumed at a level of p < 0.05.
Results and discussion
Isolation and identification of the compounds
The rhizome of O. japonicus was extracted with
70% ethanol, and the extracts were subjected to
D101 resin column, silica gel column and Sephadex
LH-20 for fractionation. Repeated column chroma-
tography was performed for each fraction to yield
13 compounds. The structures of the isolated com-
pounds were identified by comparing their ESI-MS,
1D- and 2D-NMR spectroscopic data with values
reported in the literature, as Ophiopogonanone E
(1); 4-O-(2-Hydroxy-1-hydroxymethylethyl)- dihy-
droconiferyl alcohol (2); Oleic acid (3); Palmitic
acid (4); desmethylisoophiopogononeB [5,7-dihy-
droxy-3-(4′-hydroxybenzyl)-8-methylchromoe] (5);
5,7-dihydroxy-6-methyl-3-(4′-hydroxy-benzyl)-chroman-
4-one (6); 5,7-dihydroxy −6-methyl-3-(4′-hydroxybenzyl)
chromone (7); 3-(2,4-Dihydroxybenzyl)-5-hydroxyl- 7,8-
dimethoxy-6-methylchroman-4-one (8); 5,7-dihydroxy-3-
(4′-hydroxybenzyl) chromone (9); 4′-O-Demethylo-
phiopogonanone E (10); Ophiopogonone D (11);
5,7- dihydroxy-6-methyl-3-(2′,4′-dihydroxybenzyl)
chroman-4-one (12); Daucosterol (13) respectively.
Among these compounds, compound 10 was con-
sidered as a new compound, additionally, compound
2 and 12 were isolated from the rhizome of O.
japonicus for the first time. The spectral data of the
13 compounds were described in detail below and
the structures were shown in Fig. 2.
Ophiopogonanone E (1). Yellow amorphous powder;
Its positive-ion ESI-MS (m/z) displayed quasi-molecular
Zhao et al. BMC Complementary and Alternative Medicine  (2017) 17:7 Page 4 of 12
ion peaks at 361 [M +H]+, 743 [2 M +Na]+, indicating a
molecular weight of 360, molecular formula of
C19H20O7.
1H-NMR (DMSO-d6, 500 MHz): δ 12.28
(1H, s, 5-OH), 6.95 (1H, dd, J = 8.3 Hz, H-6′), 6.40 (1H,
d, J = 2.6 Hz, H-3′), 6.34 (1H, dd, J = 8.3, 2.6 Hz, H-5′),
4.28 (1H, dd, J = 11.4, 4.3 Hz, H-2a), 4.14 (1H, dd, J =
11.4, 7.4 Hz, H-2b), 3.67 (3H, s, 4′-OCH3), 3.63 (3H, s,
8-OCH3), 3.04 (1H, dd, J = 13.6, 5.1 Hz, H-9a), 2.95
(1H, m, H-3), 2.55 (1H, dd, J = 13.6, 9.6 Hz, H-9b), 1.90
(3H, s, 6-CH3).
13C-NMR (DMSO-d6, 125 MHz): δ 69.3
(C-2), 44.4 (C-3), 198.5 (C-4), 156.6 (C-5), 103.4 (C-6),
157.5 (C-7), 127.8 (C-8), 26.7 (C-9), 151.6 (C-10), 100.8
(C-11), 116.5 (C-1′), 156.3 (C-2′), 101.3 (C-3′), 159.0
(C-4′), 104.2 (C-5′), 131.3 (C-6′), 7.3 (6-CH3), 54.9 (4′-
OCH3), 60.8 (8-OCH3). Based on the above results and
compared the spectral data with literature [19], com-
pound 1 was identified as Ophiopogonanone E.
4-O-(2-Hydroxy-1-hydroxymethylethyl)-dihydroconiferyl
alcohol (2). White amorphous powder; Its positive-ion
ESI-MS (m/z) displayed quasi-molecular ion peaks at 279
[M+Na]+, indicating a molecular weight of 256, molecu-
lar formula of C13H20O5.
1H-NMR (CD3OD, 300 MHz): δ
6.98 (1H, d, J = 8.2 Hz, H-5), 6.85 (1H, d, J = 2.0 Hz, H-2),
6.73 (1H,dd, J = 8.2, 2.0 Hz, H-6), 4.15 (1H, m, H-2′), 3.83
(3H, s, OCH3), 3.68-3.80 (4H, m, H-1′, H-3′), 3.55 (2H, t,
J = 6.5 Hz, H-9), 2.62 (2H, t, J = 7.7 Hz, H-7), 1.81 (2H, m,
H-8). 13C-NMR (CD3OD, 75 MHz): δ 138.3 (C-1), 114.1
(C-2), 152.0 (C-3), 146.8 (C-4), 119.5 (C-5), 122.0 (C-6),
32.8 (C-7), 35.5 (C-8), 62.2 (C-9), 56.5 (OCH3), 62.0 (C-1′,
C-3′), 83.4 (C-2′). Based on the above results and com-
pared the spectral data with literature [20], compound 2
was identified as 4-O-(2-Hydroxy-1-hydroxymethylethyl)-
dihydroconiferyl alcohol.
Oleic acid (3). Yellow syrup; Molecular weight of 282
and molecular formula of C18H34O2.
1H-NMR
(CD3OD, 500 MHz): δ 5.27-5.39 (2H, m, H-9 and H-
10), 2.26 (2H, t, J = 7.4 Hz, H-2), 2.05 (4H, q-like, J =
6.8 Hz, H-8 and H-11), 1.58 (2H, m, H-3), 1.23-1.39
Fig. 2 Chemical structures for compounds 1–13 isolated from ROJ-ext
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(20H, m, H-4–H-7 and H-12–H-17), 0.90 (3H, t, J = 7.0 Hz,
H-18). 13C-NMR (CD3OD, 125 MHz): δ 177.7 (s, C-1),
130.9 (d, C-9), 129.1 (d, C-10), 35.0 (t, C-2), 33.1 (t, C-16),
30.2-30.8 (t, C-4–C-7 and C-12–C-15), 28.1 (t, C-8 and C-
11), 26.1 (t, C-3), 23.6 (t, C-17), 14.4 (q, C-18).
Palmitic acid (4). Colorless glue-like solid; Molecular
weight of 256 and molecular formula of C16H32O2.
1H-
NMR (CDCl3, 500 MHz): δ 2.33 (2H, t, J = 7.4 Hz, H-2),
1.62 (2H, m, H-3), 1.16-1.37 (24H, m, H-4–H-15), 0.87
(3H, t, J = 7.1 Hz, H-16). 13C-NMR (CDCl3, 125 MHz): δ
179.6 (s, C-1), 34.0 (t, C-2), 31.9 (t, C-14), 29.0-29.7 (t,
C-4–C-13), 24.7 (t, C-3), 22.6 (t, C-15), 14.1 (q, C-16).
desmethylisoophiopogonone B [5,7-dihydroxy-3-(4′-
hydroxybenzyl)-8- methylchromone] (5). Pale yellow
needle-like crystals; Its positive-ion ESI-MS (m/z) dis-
played quasi-molecular ion peaks at 299 [M +H]+, indi-
cating a molecular weight of 298, molecular formula of
C17H14O5.
1H-NMR (CD3OD, 300 MHz): δ 7.72 (1H, s,
H-2), 7.09 (2H, d, J = 8.4 Hz, H-2′, H-6′), 6.71 (2H, d,
J = 8.4 Hz, H-3′, H-5′), 6.21 (1H, s, H-6), 3.59 (2H, s,
H-9), 2.08 (3H, s, 8-CH3).
13C-NMR (CD3OD, 75 MHz):
δ 155.3 (C-2), 123.8 (C-3), 183.2 (C-4), 160.8 (C-5),
99.1 (C-6), 163.3 (C-7), 103.5 (C-8), 30.7 (C-9), 157.2
(C-10), 105.9 (C-11), 130.8 (C-1′), 130.9 (C-2′, C-6′),
116.3 (C-3′, C-5′), 157.0 (C-4′), 7.3 (8-CH3). Based on
the above results and compared the spectral data with
literature [21], compound 5 was identified as 5,7-dihy-
droxy-3-(4′-hydroxybenzyl)-8- methylchromone.
5,7-dihydroxy-6-methyl-3-(4’-hydroxy-benzyl)-chroman-
4-one (6). Yellow amorphous powder; Its positive-ion
ESI-MS (m/z) displayed quasi-molecular ion peaks at
323 [M + Na]+, indicating a molecular weight of 300,
molecular formula of C17H16O5.
1H-NMR (CD3OD,
300 MHz): δ 7.03 (2H, d, J = 8.4 Hz, H-2′, H-6′), 6.72
(2H, d, J = 8.4 Hz, H-3′, H-5′), 5.87 (1H, s, H-8), 4.18
(1H, dd, J = 11.4, 4.1 Hz, H-2a), 4.01 (1H, dd, J = 11.4,
7.0 Hz, H-2b), 3.07 (1H, dd, J = 13.5, 4.2 Hz, H-9a), 2.74
(1H, m, H-3), 2.60 (1H, dd, J = 13.5, 10.4 Hz, H-9b),
1.92 (3H, s, 6-CH3).
13C-NMR (CD3OD, 75 MHz): δ
70.0 (C-2), 48.2 (C-3), 199.5 (C-4), 162.9 (C-5), 105.3
(C-6), 166.0 (C-7), 94.9 (C-8), 33.1 (C-9), 162.2 (C-10),
102.6 (C-11), 130.3 (C-1′), 131.1 (C-2′, C-6′), 116.4 (C-
3′, C-5′), 157.1 (C-4′), 7.0 (6-CH3). Based on the above
results and compared the spectral data with literature
[22], compound 6 was identified as 5,7-dihydroxy-6-
methyl-3-(4′-hydroxy-benzyl)-chroman-4-one.
5,7-dihydroxy-6-methyl-3-(4'-hydroxybenzyl) chromone
(7). White amorphous powder; Its positive-ion ESI-MS
(m/z) displayed quasi-molecular ion peaks at 299 [M +
H]+, indicating a molecular weight of 298, molecular for-
mula of C17H14O5.
1H-NMR (CD3OD, 300 MHz): δ 7.63
(1H, s, H-2), 7.08 (2H, d, J = 8.4 Hz, H-2′, H-6′), 6.71
(2H, d, J = 8.4 Hz, H-3′, H-5′), 6.30 (1H, s, H-8), 3.59
(2H, s, H-9), 2.02 (3H, s, 6-CH3).
13C-NMR (CD3OD,
75 MHz): δ 154.9 (C-2), 124.2 (C-3), 182.8 (C-4), 160.2
(C-5), 108.7 (C-6), 163.8 (C-7), 93.6 (C-8), 30.8 (C-9),
157.6 (C-10), 105.6 (C-11), 130.8 (C-1′), 130.9 (C-2′, C-
6′), 116.3 (C-3′, C-5′), 157.0 (C-4′), 7.4 (6-CH3). Based
on the above results and compared the spectral data
with literature [22], compound 7 was identified as 5,7-di-
hydroxy-6-methyl-3-(4′-hydroxybenzyl) chromone.
3-(2,4-Dihydroxybenzyl)-5-hydroxy-7,8-dimethoxy-6-
methylchroman-4-one (8). Yellow syrup; Its positive-ion
ESI-MS (m/z) displayed quasi-molecular ion peaks at
361 [M +H]+, indicating a molecular weight of 360, mo-
lecular formula of C19H20O7.
1H-NMR (CD3OD,
700 MHz): δ 6.86 (1H, d, J = 8.1 Hz, H-6′), 6.29 (1H, d,
J = 2.2 Hz, H-3′), 6.23 (1H, dd, J = 8.1, 2.2 Hz, H-5′),
4.30 (1H, dd, J = 11.4, 4.1 Hz, H-2a), 4.16 (1H, dd, J =
11.4, 7.6 Hz,H-2b), 3.92 (3H, s, 7-OCH3), 3.72 (3H, s, 8-
OCH3), 3.14 (1H, dd, J = 13.5, 5.0 Hz, H-9a), 2.98 (1H,
m, H-3), 2.56 (1H, dd, J = 13.5, 9.8 Hz, H-9b), 1.97 (3H,
s, 6-CH3).
13C-NMR (CD3OD, 75 MHz): δ 70.9 (C-2),
46.8 (C-3), 201.3 (C-4), 157.8 (C-5), 111.2 (C-6), 160.9
(C-7), 134.2 (C-8), 28.1 (C-9), 154.2 (C-10), 105.2 (C-11),
116.6 (C-1′), 157.6 (C-2′), 103.5 (C-3′), 158.3 (C-4′),
107.4 (C-5′), 132.6 (C-6′), 7.7 (6-CH3), 61.3 (7-OCH3),
61.7 (8-OCH3). Based on the above results and com-
pared the spectral data with literature [21], compound 8
was identified as 3-(2,4-Dihydroxybenzyl)-5-hydroxy-
7,8-dimethoxy-6-methylchroman-4- one.
5,7-dihydroxy-3-(4' - hydroxybenzyl) chromone (9). Yel-
low needle-like crystals; Its positive-ion ESI-MS (m/z)
displayed quasi-molecular ion peaks at 285 [M +H]+, in-
dicating a molecular weight of 284, molecular formula of
C16H12O5.
1H-NMR (CD3OD, 500 MHz): δ 7.68 (1H, s,
H-2), 7.09 (2H, d, J = 8.6 Hz, H-2′, H-6′), 6.71 (2H, d, J
= 8.6 Hz, H-3′, H-5′), 6.26 (1H, d, J = 2.1Hz, H-8), 6.16
(1H, d, J = 2.1 Hz, H-6), 3.60 (2H, s, H-9). 13C-NMR
(CD3OD, 125 MHz): δ 155.2 (C-2), 124.4 (C-3), 182.8
(C-4), 163.5 (C-5), 99.9 (C-6), 165.9 (C-7), 94.7 (C-8),
30.7 (C-9), 159.9 (C-10), 106.0 (C-11), 130.7 (C-1′),
130.9 (C-2′, C-6′), 116.3 (C-3′, C-5′), 157.0 (C-4′).
Based on the above results and compared the spectral data
with literature [23], compound 9 was identified as 5,7-dihy-
droxy-3-(4' - hydroxybenzyl) chromone
4'-O-Demethylophiopogonanone E (10) was obtained as
a white amorphous powder with molecular formula of
C18H18O7 determined by its HR-ESI-MS at m/z
347.1160 [M +H]+ (calcd. for 347.1131) and the NMR
spectra. 1H-NMR (CD3OD, 500 MHz): δ 6.86 (1H, d, J =
8.1 Hz, H-6′), 6.29 (1H, d, J = 2.4 Hz, H-3′), 6.23 (1H,
dd, J = 8.1, 2.4 Hz, H-5′), 4.27 (1H, dd, J = 11.3, 4.6 Hz,
H-2a), 4.14 (1H, dd, J = 11.3, 7.4 Hz, H-2b), 3.71 (3H, s,
OCH3), 3.14 (1H, dd, J = 13.7, 4.9 Hz, H-9a), 2.93 (1H,
m, H-3), 2.57 (1H, dd, J = 13.7, 10.0 Hz, H-9b), 1.95 (3H,
s, 6-CH3).
13C-NMR (CD3OD, 125 MHz): δ 70.8 (C-2),
46.6 (C-3), 200.4 (C-4), 158.3 (C-5), 105.1 (C-6), 158.8
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(C-7), 129.0 (C-8), 28.3 (C-9), 153.1 (C-10), 102.4 (C-11),
116.8 (C-1′), 157.6 (C-2′), 103.5 (C-3′), 158.5 (C-4′),
107.5 (C-5′), 132.6 (C-6′), 7.2 (6-CH3), 61.6 (OCH3).
The 1H NMR spectrum of 10 showed the presence of a
methoxy group at δ 3.71 (3H, s), a methyl group at-
tached to an aromatic nucleus at δ 1.95 (3H, s, 6-CH3),
and three ABX aromatic proton signals appeared at δ
6.29 (1H, d, J = 2.4 Hz, H-3′), 6.23 (1H, dd, J = 8.1,
2.4 Hz, H-5′), and 6.86 (1H, d, J = 8.1 Hz, H-6′). In
addition, the 1H NMR signals at δ 4.27 (1H, dd, J = 11.3,
4.6 Hz, H-2a), 4.14 (1H, dd, J = 11.3, 7.4 Hz, H-2b), and
2.93 (1H, m, H-3) were observed, which indicated the γ-
dihydropyrone moiety. Combined with the two benzyl-
methylene protons appeared at δH 3.14 (1H, dd, J = 13.7,
4.9 Hz, H-9a) and 2.57 (1H, dd, J = 13.7, 10.0 Hz, H-9b),
compound 10 was presumed to be a homoisoflavonoid
derivative [19]. After carefully analysis of the NMR spec-
tra of 10, the spectral properties were found very similar
to those of ophiopogonanone E [19]. The notable differ-
ence was the presence of a hydroxy group instead of a
methoxy group at C-4′ in 10, compared with ophiopo-
gonanone E. The change and the structure of 10 were
further confirmed by HMBC correlations from δH 3.71
(3H, s, OCH3) to C-8 (δC 129.0), from δH 1.95 (3H, s, 6-
CH3) to C-6 (δC 105.1), C-5 (δC 158.3) and C-7 (δC
158.8), from δH 4.27 (1H, dd, J = 11.3, 4.6 Hz, H-2a),
4.14 (1H, dd, J = 11.3, 7.4 Hz, H-2b), 3.14 (1H, dd, J =
13.7, 4.9 Hz, H-9a), and 2.57 (1H, dd, J = 13.7, 10.0 Hz,
H-9b) to C-4 (δC 200.4), and from δH 6.86 (1H, d, J =
8.1 Hz, H-6′) to C-9 (δC 28.3), C-2′ (δC 157.6), and C-4′
(δC 158.5). Therefore, the chemical structure of 10 was
determined to be 3-(2,4-dihydroxybenzyl)-5,7-dihy-
droxy-8- methoxy-6-methylchroman-4-one and named
as 4′-O-demethylophiopogonanone E. There have been
no related reports about the structure of compound 10
in SciFinder scholar, suggesting that the compound may
be a new compound, the NMR signals of this homoiso-
flavonoid were reported and completely assigned for the
first time.
Ophiopogonone D (11). Yellow amorphous powder; Its
positive-ion ESI-MS (m/z) displayed quasi-molecular ion
peaks at 315 [M +H]+, 651 [2 M +Na]+, indicating a
molecular weight of 314, molecular formula of
C17H14O6.
1H-NMR (CD3OD, 500 MHz): δ 7.65 (1H, s,
H-2), 6.96 (1H, d, J = 8.2 Hz, H-6′), 6.31 (1H, s, H-8),
6.30 (1H, d, J = 2.5Hz, H-3′), 6.25 (1H, dd, J = 8.2, 2.4Hz,
H-5′), 3.57 (2H, s, H-9), 2.03 (3H, s, H-12). 13C-NMR
(CD3OD, 125 MHz): δ 155.1 (C-2), 123.4 (C-3), 183.2
(C-4), 160.1 (C-5), 108.8 (C-6), 164.0 (C-7), 93.7 (C-8),
25.6 (C-9), 157.7 (C-10), 105.5 (C-11), 7.4 (C-12), 117.2
(C-1′), 158.4 (C-2′), 103.9 (C-3′), 157.2 (C-4′), 107.9 (C-
5′), 132.3 (C-6′). Based on the above results and com-
pared the spectral data with literature [24], compound
11 was identified as Ophiopogonone D.
5,7-dihydroxy-6-methyl-3-(2',4'-dihydroxybenzyl) chro-
man-4-one (12). Yellow needle-like crystals; Molecular
weight of 316, molecular formula of C17H16O6.
1H-NMR
(CD3OD, 500 MHz): δ 6.86 (1H, d, J = 8.2 Hz, H-6′),
6.30 (1H, d, J = 2.4 Hz, H-3′), 6.24 (1H, dd, J = 8.2,
2.4 Hz, H-5′), 5.88 (1H, s, H-8), 4.20 (1H, dd, J = 11.4,
4.2 Hz, H-2a), 4.05 (1H, dd, J = 11.4, 7.6 Hz, H-2b),
3.15 (1H, dd, J = 13.7, 4.8 Hz, H-9a), 2.93 (1H, m, H-
3), 2.55 (1H, dd, J = 13.7, 10.1 Hz, H-9b), 1.93 (3H, s,
6-CH3).
13C-NMR (CD3OD, 125 MHz): δ 70.6 (C-2),
46.5 (C-3), 200.3 (C-4), 165.9 (C-5), 105.2 (C-6),
162.8 (C-7), 94.8 (C-8), 28.2 (C-9), 162.3 (C-10), 102.6
(C-11), 116.9 (C-1′), 157.5 (C-2′), 103.5 (C-3′), 158.3
(C-4′), 107.5 (C-5′), 132.6 (C-6′), 7.0 (6-CH3). Based
on the above results and compared the spectral data
with literature [25], compound 12 was identified
as 5,7-dihydroxy-6-methyl-3-(2′,4′- dihydroxybenzyl)
chroman-4-one.
Daucosterol (13). White powder; Molecular weight of
576, molecular formula of C35H60O6.
1H-NMR (DMSO-
d6, 500 MHz): δ 5.32 (1H, br s, H-6), 4.84-4.93 (3H, 2′-
OH, 3′-OH, 4′-OH), 4.44 (1H, t, J = 5.5 Hz, 6′-OH),
4.21 (1H, d, J = 7.8 Hz, H-1′), 2.35 (1H, br d, J = 12.4 Hz,
H-4a), 2.11 (1H, br t, J = 12.4 Hz, H-4b), 0.94 (3H, s, H-
19), 0.89 (3H, d, J = 6.3 Hz, H-21), 0.81 (3H, t, J = 6.6 Hz,
H-29), 0.80 (3H, d, J = 6.9 Hz, H-27), 0.78 (3H, d, J =
6.9 Hz, H-26), 0.64 (3H, s, H-18). 13C-NMR (DMSO-d6,
125 MHz): δ 36.8 (C-1), 29.3 (C-2), 76.9 (C-3), 38.3 (C-
4), 140.5 (C-5), 121.2 (C-6), 31.4 (C-7, C-8), 49.6 (C-9),
36.2 (C-10), 20.6 (C-11), 40.1 (C-12), 41.9 (C-13), 55.4
(C-14), 23.9 (C-15), 27.8 (C-16), 56.2 (C-17), 11.7 (C-18),
19.1 (C-19), 35.5 (C-20), 18.6 (C-21), 33.4 (C-22), 25.4
(C-23), 45.1 (C-24), 28.7 (C-25), 18.9 (C-26), 19.7 (C-27),
22.6 (C-28), 11.8 (C-29), 100.8 (C-1'), 73.5 (C-2'), 76.8
(C-3'), 70.1 (C-4'), 76.8 (C-5'), 61.1 (C-6'). Based on the
above results and compared the spectral data with
literature [26], compound 13 was identified as
Daucosterol.
Effects of isolated compounds (1–13) on Cell Viability of
RAW 264.7Macrophages
The cytotoxicity of these compounds on the prolifera-
tion of RAW264.7 cells was measured using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide
(MTT) assay [27]. The results were shown as relative
cell viability referred to control (equal to 100%). In this
study, 13 compounds of O. japonicas were shown dif-
ferent cytotoxicity effect to RAW 264.7 cells. The safe
concentration of compound 2, 4 and 13 is 100 μg/mL,
while compound 3, 5 and 10 is 50 μg/mL, which is the
cell survival probability more than 80%, the other com-
pounds have some cytotoxicity at the concentrations
(1–100 μg/mL) (Fig. 3).
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Effects of isolated compounds (1–13) on the Production
of NO in LPS-induced RAW264.7 Macrophages
To evaluate the effect of compounds (1–13) on NO pro-
duction in LPS-stimulated RAW 264.7 cells, we mea-
sured the nitrite concentration in the cultured media
using Griess reagent [28]. Compared with the LPS
group, the anti-inflammatory activities of compounds 3,
4, 5, 7 and 10 increased in accordance with the increase
in concentration. As shown in Fig. 4, compounds 3, 4, 5,
7 and 10 displayed an inhibitory potency, with IC50
values of 80.2 ± 2.3, 33.4 ± 2.9, 14.1 ± 1.5, 10.9 ± 0.8 and
66.4 ± 3.5 μg/mL, respectively. Moreover, compounds 4,
5 and 7 showed stronger anti-inflammatory abilities than
the positive control DXM at the concentration of 50 μg/
mL (p < 0.01), in which compounds 5 and 7 belonged to
homoisoflavonoids. Thus, it is possible to demonstrate
that the anti-inflammatory activity of O. japonicas might
be derived from its rich in homoisoflavonoids com-
pounds, however, there are few literatures reported on
its anti-inflammatory mechanism.
Effects of the compounds 3–5, 7 and 10 on the
Production of Pro-Inflammatory Cytokines (IL-1β and IL-6)
in LPS-induced RAW264.7 Macrophages
Because IL-1β and IL-6 are early secreted pro-
inflammatory cytokines and their elevated levels can be
detected in a variety of acute and chronic inflammatory
diseases [29], we measured IL-1β and IL-6 production in
the supernatant of RAW 264.7 cells by ELISA. The LPS
group significantly increased IL-1β and IL-6 production
compared with the control group. The release of both
cytokines were remarkably decreased in a dose-
Fig. 3 Effects of isolated compounds 1–7 (a) and 8–13 (b) on cell viability of RAW 264.7 macrophages. Cells were incubated for 24 h with the
indicated concentrations of compounds (1, 5, 25, 50 and 100 μg/mL). data are expressed as mean ± S.D. Of three independent experiments.
* p < 0.05 and ** p < 0.01 versus the control group
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Fig. 4 Effects of isolated compounds (3–5, 7 and 10) on the production of NO in LPS-induced RAW264.7 macrophages. Cells were pre-treated for
2 h with indicated concentrations of (3–5, 7 and 10) and then stimulated with LPS (final concentration 1 μg/mL) for another 24 h. Data are
expressed as mean ± S.D. Of three independent experiments. * p < 0.05 and ** p < 0.01 versus the LPS group, △p < 0.05 and △△p < 0.01 versus the
DXM group
Fig. 5 Effects of the compounds 3–5, 7 and 10 on the production of pro-inflammatory cytokines IL-1β (a) and IL-6 (b) in LPS-induced RAW264.7
macrophages. Cells were pre-treated for 2 h with indicated concentrations of 3–5, 7 and 10 and then stimulated with LPS (final concentration
1 μg/mL) for another 24 h. Data are expressed as mean ± S.D. Of three independent experiments. ## p < 0.01 as compared with the control group,
* p < 0.05 and ** p < 0.01 versus the LPS group, △p < 0.05 and △△p < 0.01 versus the DXM group
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dependent manner (p < 0.05) in the groups pretreated
with compounds 3, 4, 5, 7 and 10 (Fig. 5a and b). More-
over, the IL-1β IC50 values of compounds 4, 5 and 10
were 65.3 ± 6.8, 64.3 ± 7.9 and 32.5 ± 3.5 μg/mL, respect-
ively. In addition to IL-6, compounds 3, 4, 5, 7 and 10
displayed an inhibitory potency, with IC50 values of 58.9
± 6.8, 71.6 ± 11.7, 32.4 ± 3.6, 11.5 ± 2.8 and 13.4 ± 2.3 μg/
mL, respectively. This result indicated that 4'-O-
Demethylophiopogonanone E (10) efficiently suppressed
LPS-induced IL-1β and IL-6 production, especially, it
showed stronger anti-inflammatory ability than DXM at
the concentration of 50 μg/mL (p < 0.05). Its effect on
the LPS-induced IL-1β, IL-6 and iNOS mRNA expres-
sions needs further investigation.
Effects of 4'-O-Demethylophiopogonanone E (10) on the
mRNA Expression of IL-1β, IL-6 and iNOS in LPS-induced
RAW264.7 Macrophages
4'-O-Demethylophiopogonanone E (10) exhibited
strong inhibitory effect on the LPS-induced IL-1β and
IL-6 production, however, few studies were involved in
the exact mechanism of the anti-inflammatory effect of
4'-O-Demethylophiopogonanone E. As shown in Fig. 6,
compared to the control group, treatment with LPS for
12 h significantly (p < 0.01) increased mRNA expression
of IL-1β, IL-6 and iNOS. Additionally, pre-treatment
with 4'-O-Demethylophiopogonanone E (at the concen-
tration of 25, 50 μg/mL) for 2 h could significantly in-
hibit the expression of IL-1β, IL-6 and iNOS in a dose-
dependent manner (p < 0.01). The results suggested that
4'-O-Demethylophiopogonanone E decreased NO, IL-
1β and IL-6 production by decreasing the iNOS, IL-1β
and IL-6 mRNA expression at the transcriptional level.
Effects of 4'-O-Demethylophiopogonanone E (10) on
MAPKs Signaling Pathways Activation in LPS-induced
RAW264.7 Macrophages
Previous studies have indicated that IL-1β and IL-6 are
crucial factors involved in all kinds of inflammatory
processes that can be regulated by activation of NF-κB
[30–32]. In addition, MAPKs are also known to be im-
portant for the transcriptional NF-κB pathway activa-
tion and are related to iNOS expression [33]. To
investigate whether the suppression of inflammatory re-
sponses by 4'-O-Demethylophiopogonanone E was me-
diated through the MAPKs pathways, we estimated the
effects of compound 10 on the LPS-stimulated phos-
phorylation of ERK1/2 and JNK in RAW 264.7 cells by
Western blotting. As shown in Fig. 7, this research
demonstrated that LPS significantly increased the phos-
phorylation of MAPKs signaling proteins, while
pre-treatment with compound 10 considerably
Fig. 6 Effects of 4'-O-demethylophiopogonanone E (10) on the mRNA expression of IL-1β (a), IL-6 (b) and iNOS (c) in LPS-induced RAW264.7
macrophages. Cells were pre-treated for 2 h with indicated concentrations of 10 and then stimulated with LPS (final concentration 1 μg/mL)
for another 12 h. Data are expressed as mean ± S.D. Of three independent experiments. ## p < 0.01 as compared with the control group,
* p < 0.05 and ** p < 0.01 versus the LPS group, △ p < 0.05 and △△ p < 0.01 versus the DXM group
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inhibited the phosphorylation of ERK1/2 and JNK,
however it did not have a distinct dose-dependent pat-
tern. In conclusion, our findings suggested that 4'-O-
Demethylophiopogonanone E might decrease NO, IL-
1β and IL-6 production via inhibitions of the MAPKs
signaling pathways.
Conclusion
In this study, a new compound 4'-O-Demethylophiopo-
gonanone E was isolated and identified from the rhi-
zome of O. japonicas. Moreover, we firstly investigated
the effect and mechanism of 4'-O-Demethylophiopogo-
nanone E on LPS-stimulated NO and pro-inflammatory
cytokines including IL-1β and IL-6. NO is synthesized
from L-arginine by iNOS, and its overproduction is in-
volved in cytotoxicity and tissue damage in the inflam-
matory process [34, 35]. Overexpression of iNOS by
inflammatory agents accompanied with inflammatory
disorder including IL-1β and IL-6, which are resulted in
acute and chronic response to inflammatory diseases
[36]. In the present study, we clearly demonstrated that
4'-O-Demethylophiopogonanone E significantly inhibited
LPS-stimulated NO production and pro-inflammatory
cytokines (IL-1β and IL-6) in macrophages via downreg-
ulation of the mRNA expressions of iNOS, IL-1β and
IL-6 (Fig. 6).
Moreover, MAPKs have been involved in pro-inflam-
matory signaling cascades and large numbers of evidence
has demonstrated that the activation of ERK1/2
and JNK is involved in up-regulation of nitric oxide and
pro-inflammatory cytokines in LPS- induced macro-
phages [37, 38]. Thus, we assessed that 4'-O-Demethylo-
phiopogonanone E inhibited the inflammatory response
via blocking the phosphorylation of MAPKs in LPS-
stimulated macrophages. In the results of 4'-O-Demethy-
lophiopogonanone E pretreatment, we found that 4'-O-
Demethylophiopogonanone E suppressed LPS-stimulated
ERK1/2 and JNK MAPK phosphorylation (Fig. 7). This
result suggests that 4'-O-Demethylophiopogonanone E
exerted anti-inflammatory actions via inhibition of iNOS,
IL-1β and IL-6 gene expressions through suppression of
the MAPKs signaling pathways.
Consequently, based on these findings, we provide
clear evidence and molecular basis for the anti-
inflammatory mechanism of 4'-O-Demethylophiopo-
gonanone E and show great potential as a novel herbal
ingredient for the treatment of inflammatory diseases.
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